miR-142-3p inhibits cancer cell proliferation by targeting CDC25C

被引:52
作者
Cao, Xu-Chen [1 ,2 ,3 ]
Yu, Yue [1 ,2 ,3 ]
Hou, Li-Kun [1 ,2 ,3 ]
Sun, Xiao-Hu [1 ,2 ,3 ]
Ge, Jie [1 ,2 ,3 ]
Zhang, Bin [1 ,2 ,3 ]
Wang, Xin [1 ,2 ,3 ]
机构
[1] Tianjin Med Univ Canc Inst & Hosp, Dept Breast Canc 1, Natl Clin Res Ctr Canc, Tianjin 300060, Peoples R China
[2] Key Lab Canc Prevent & Therapy, Tianjin 300060, Peoples R China
[3] Tianjin Med Univ, Key Lab Breast Canc Prevent & Therapy, Minist Educ, Tianjin 300060, Peoples R China
基金
中国国家自然科学基金;
关键词
TUMOR-SUPPRESSOR; MITOTIC EXIT; MICRORNA-142-3P; OVEREXPRESSION; PHOSPHATASES; EXPRESSION; REGULATOR; INVASION; CYCLE;
D O I
10.1111/cpr.12235
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
ObjectivesMicroRNAs (miRNAs) contribute to control of cell cycle progression and are frequently deregulated in cancer. The focus of this study was to determine effects of miR-142-3p on the cell cycle progression and cancer cell proliferation. Materials and methodsRT-qPCR was performed to determine expression of miR-142-3p in a range of cancer cell lines and in clinical cancer specimens. To further understand its role, we restored its expression in cancer cell lines by transfection with miR-142-3p mimics or inhibitors. Effects of miR-142-3p on cell cycle progression and cell proliferation were also determined. ResultsmiR-142-3p was down-regulated in both cancer cell lines and cancer specimens. Its overexpression suppressed proliferation, whereas its depletion promoted it. In addition, miR-142-3p lead to cell cycle arrest in G2/M. Moreover, CDC25C was identified as being a target of miR-142-3p, ectopic expression of which reversed suppression of cell proliferation. ConclusionsOur observations suggest that miR-142-3p functioned as a tumor suppressor by targeting CDC25C.
引用
收藏
页码:58 / 68
页数:11
相关论文
共 29 条
[1]   MicroRNAs: Target Recognition and Regulatory Functions [J].
Bartel, David P. .
CELL, 2009, 136 (02) :215-233
[2]   CDC25 phosphatases in cancer cells: key players? Good targets? [J].
Boutros, Rose ;
Lobjois, Valerie ;
Ducommun, Bernard .
NATURE REVIEWS CANCER, 2007, 7 (07) :495-507
[3]   MicroRNA-142-3p inhibits cell proliferation and invasion of cervical cancer cells by targeting FZD7 [J].
Deng, Boya ;
Zhang, Yi ;
Zhang, Siyang ;
Wen, Fang ;
Miao, Yuan ;
Guo, Kejun .
TUMOR BIOLOGY, 2015, 36 (10) :8065-8073
[4]   Control of mitotic exit by PP2A regulation of Cdc25C and Cdk1 [J].
Forester, Craig M. ;
Maddox, Jessica ;
Louis, Justin V. ;
Goris, Jozef ;
Virshup, David M. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (50) :19867-19872
[5]   MicroRNAs in diseases and drug response [J].
Garofalo, Michela ;
Condorelli, Gerolama ;
Croce, Carlo Maria .
CURRENT OPINION IN PHARMACOLOGY, 2008, 8 (05) :661-667
[6]   MicroRNAs in Cancer [J].
Lee, Yong Sun ;
Dutta, Anindya .
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE, 2009, 4 :199-227
[7]   Cdc25 phosphatases and cancer [J].
Kristjánsdóttir, K ;
Rudolph, J .
CHEMISTRY & BIOLOGY, 2004, 11 (08) :1043-1051
[8]   Reverse Genetics Screen in Zebrafish Identifies a Role of miR-142a-3p in Vascular Development and Integrity [J].
Lalwani, Mukesh Kumar ;
Sharma, Meenakshi ;
Singh, Angom Ramcharan ;
Chauhan, Rajendra Kumar ;
Patowary, Ashok ;
Singh, Naresh ;
Scaria, Vinod ;
Sivasubbu, Sridhar .
PLOS ONE, 2012, 7 (12)
[9]   Overexpression of Cdc25C predicts response to radiotherapy and survival in esophageal squamous cell carcinoma patients treated with radiotherapy followed by surgery [J].
Li, Bao-Zhong ;
Chen, Zhao-Li ;
Shi, Su-Sheng ;
Feng, Xiao-Li ;
Tan, Xiao-Gang ;
Zhou, Fang ;
He, Jie .
CHINESE JOURNAL OF CANCER, 2013, 32 (07) :403-409
[10]   MiR-142-3p as a potential prognostic biomarker for esophageal squamous cell carcinoma [J].
Lin, Rui-Jun ;
Xiao, Da-Wei ;
Liao, Lian-Di ;
Chen, Tao ;
Xie, Ze-Feng ;
Huang, Wei-Zhe ;
Wang, Wei-Sen ;
Jiang, Tai-Feng ;
Wu, Bing-Li ;
Li, En-Min ;
Xu, Li-Yan .
JOURNAL OF SURGICAL ONCOLOGY, 2012, 105 (02) :175-182